This pooled analysis of the phase III BLOOM and BLOSSOM trials shows that lorcaserin 10 mg twice daily , in combination with diet and exercise , is safe and tolerable , and is associated with statistically significant weight loss and clinically relevant improvements in cardiometabolic parameters .